Pharmacoepidemiology

Our research focuses on describing and understanding how medications are prescribed, dispensed, and used by different population groups, as well as the effects observed in terms of improved health, side effects, and costs of drug therapy. The approach is primarily registry studies, but we also conduct surveys and qualitative studies.

The field of pharmacoepidemiology emerged as a research subject in the early 1960s following the drug disaster surrounding the medication thalidomide (Neurosedyn) and alarm reports regarding quality deficiencies and high costs of pharmaceuticals within healthcare.

Since then, there has been rapid development. Today, the subject encompasses analyses of how medications are prescribed and used, as well as studies on the benefits and side effects of drug treatment. With increasingly sophisticated medications being studied on fewer individuals when they enter the market, rising drug usage, and an increased focus on sustainable pharmaceutical use socially, economically, and ecologically, pharmacoepidemiology is a rapidly expanding research area. More about pharmacoepidemiology and its future can be read in an issue of SVEPET (2019 No. 4) and the article 'Intriguing Future of Pharmacoepidemiology' (National Library of Medicine).

EuroDURG banner

Contact

  • Visiting Address: BMC, Husargatan 3, A1:2, A2:2, A3:3, B3:3, B3:4, C2:2
  • Letter and Postal Address: Box 580, SE-751 23 Uppsala

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Twitter
Uppsala University on Youtube
Uppsala University on Linkedin